Isabelle Miconnet

Publications | Phd and Masters theses

Advanced search is available through Serval

Publications can be managed by accessing Serval via MyUnil


33 publications

2013 | 2012 | 2011 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1995 | 1994 | 1993 | 1992 | 1990 |
Rapid Perturbation in Viremia Levels Drives Increases in Functional Avidity of HIV-specific CD8 T Cells.
Viganò S., Bellutti Enders F., Miconnet I., Cellerai C., Savoye A.L., Rozot V., Perreau M., Faouzi M., Ohmiti K., Cavassini M. et al., 2013. Plos Pathogens, 9 (7) pp. e1003423.
 
Probing the T-cell receptor repertoire with deep sequencing.
Miconnet I., 2012. Current Opinion In Hiv and Aids, 7 (1) pp. 64-70.
 
Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection.
Roger T., Lugrin J., Le Roy D., Goy G., Mombelli M., Koessler T., Ding X.C., Chanson A.L., Reymond M.K., Miconnet I. et al., 2011. Blood, 117 (4) pp. 1205-1217.
 
Large TCR diversity of virus-specific CD8 T cells provides the mechanistic basis for massive TCR renewal after antigen exposure.
Miconnet Isabelle, Marrau Angélique, Farina Alex, Taffé Patrick, Vigano Selena, Harari Alexandre, Pantaleo Giuseppe, 2011. Journal of Immunology, 186 (12) pp. 7039-7049. Peer-reviewed.
 
A soluble hexameric form of CD40 ligand activates human dendritic cells and augments memory T cell response.
Miconnet I., Pantaleo G., 2008. Vaccine, 26 (32) pp. 4006-4014. Peer-reviewed.
 
Induction of multiple CD8+ T cell responses against the inducible Hsp70 employing an Hsp70 oligoepitope peptide.
Faure O., Graff-Dubois S., Alves P.M., Cornet S., Duffour M.T., Scardino A., Gross D.A., Miconnet I., Salcedo M., Chouaib S. et al., 2007/03. Oncology Reports, 17 (3) pp. 679-685. Peer-reviewed.
 
STEAP, a prostate tumor antigen, is a target of human CD8+ T cells
Alves P. M., Faure O., Graff-Dubois S., Cornet S., Bolonakis I., Gross D. A., Miconnet I., Chouaib S., Fizazi K., Soria J. C. et al., 2006/12. Cancer Immunology, Immunotherapy, 55 (12) pp. 1515-23.
 
CpG oligodeoxynucleotides activate dendritic cells in vivo and induce a functional and protective vaccine immunity against a TERT derived modified cryptic MHC class I-restricted epitope
Cornet S., Menez-Jamet J., Lemonnier F., Kosmatopoulos K., Miconnet I., 2006/03. Vaccine, 24 (11) pp. 1880-8.
 
Optimal organization of a polypeptide-based candidate cancer vaccine composed of cryptic tumor peptides with enhanced immunogenicity
Cornet S., Miconnet I., Menez J., Lemonnier F., Kosmatopoulos K., 2006/03. Vaccine, 24 (12) pp. 2102-9.
 
A phase I study of the optimized cryptic peptide TERT(572y) in patients with advanced malignancies
Mavroudis D., Bolonakis I., Cornet S., Myllaki G., Kanellou P., Kotsakis A., Galanis A., Nikoloudi I., Spyropoulou M., Menez J. et al., 2006. Oncology, 70 (4) pp. 306-14.
 
Critical role for Ets, AP-1 and GATA-like transcription factors in regulating mouse Toll-like receptor 4 (Tlr4) gene expression.
Roger T., Miconnet I., Schiesser A.L., Kai H., Miyake K., Calandra T., 2005. The Biochemical journal, 387 (Pt 2) pp. 355-65.
 
Inducible Hsp70 as target of anticancer immunotherapy: Identification of HLA-A*0201-restricted epitopes.
Faure O., Graff-Dubois S., Bretaudeau L., Derré L., Gross D.A., Alves P.M., Cornet S., Duffour M.T., Chouaib S., Miconnet I. et al., 2004. International Journal of Cancer, 108 (6) pp. 863-870.
 
EphA2 as target of anticancer immunotherapy: identification of HLA-A*0201-restricted epitopes
Alves P. M., Faure O., Graff-Dubois S., Gross D. A., Cornet S., Chouaib S., Miconnet I., Lemonnier F. A., Kosmatopoulos K., 2003/12. Cancer Research, 63 (23) pp. 8476-80.
 
In vivo administration of a lentiviral vaccine targets DCs and induces efficient CD8(+) T cell responses.
Esslinger C., Chapatte L., Finke D., Miconnet I., Guillaume P., Lévy F., MacDonald H.R., 2003. The Journal of clinical investigation, 111 (11) pp. 1673-1681. Peer-reviewed.
 
CpG are efficient adjuvants for specific CTL induction against tumor antigen-derived peptide.
Miconnet I., Koenig S., Speiser D., Krieg A., Guillaume P., Cerottini J.C., Romero P., 2002. Journal of Immunology, 168 (3) pp. 1212-1218. Peer-reviewed.
 
Testing mouse mammary tumor virus superantigen as adjuvant in cytotoxic T-lymphocyte responses against a melanoma tumor antigen.
Wirth S., Bille F., Koenig S., Wehrli N., Miconnet I., Lévy F., Diggelmann H., Romero P., Acha-Orbea H., 2002. International Journal of Cancer, 99 (2) pp. 201-206. Peer-reviewed.
 
Cancer vaccine design: a novel bacterial adjuvant for peptide-specific CTL induction
Miconnet I., Coste I., Beermann F., Haeuw J. F., Cerottini J. C., Bonnefoy J. Y., Romero P., Renno T., 2001/04. Journal of Immunology, 166 (7) pp. 4612-9.
 
OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway
Jeannin P., Renno T., Goetsch L., Miconnet I., Aubry J. P., Delneste Y., Herbault N., Baussant T., Magistrelli G., Soulas C. et al., 2000/12. Nature Immunology, 1 (6) pp. 502-9.
 
Amino acid identity and/or position determines the proteasomal cleavage of the HLA-A*0201-restricted peptide tumor antigen MAGE-3271-279.
Miconnet I., Servis C., Cerottini J.C., Romero P., Lévy F., 2000. Journal of Biological Chemistry, 275 (35) pp. 26892-26897.
 
Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogue.
Valmori D., Lévy F., Miconnet I., Zajac P., Spagnoli G.C., Rimoldi D., Liénard D., Cerundolo V., Cerottini J.C., Romero P., 2000. Journal of Immunology, 164 (2) pp. 1125-1131.
 
Assessment of immunogenicity of human Melan-A peptide analogues in HLA-A*0201/Kb transgenic mice
Men Y., Miconnet I., Valmori D., Rimoldi D., Cerottini J. C., Romero P., 1999/03. Journal of Immunology, 162 (6) pp. 3566-73.
 
Relative importance of CD4+ and CD8+ T cell repertoires in the development of acute graft-versus-host disease in a murine model of bone marrow transplantation
Miconnet I., de La Selle V., Bruley-Rosset M., 1998/03. Bone Marrow Transplantation, 21 (6) pp. 583-90.
 
Peripheral tolerance to host minor histocompatibility antigens in radiation bone marrow chimeras abrogates lethal GVHD while preserving GVL effect
de la Selle V., Miconnet I., Gilbert D., Bruley-Rosset M., 1995/07. Bone Marrow Transplantation, 16 (1) pp. 111-8.
 
Critical role of endogenous Mtv in acute lethal graft-versus-host disease
Miconnet I., Roger T., Seman M., Bruley-Rosset M., 1995/02. European Journal of Immunology, 25 (2) pp. 364-8.
 
Coding sequence polymorphism of Tcrg-V1, -V2, and -V4 genes in mice bearing Tcr-gA and -gC haplotypes
Roger T., Miconnet I., Bruley-Rosset M., Seman M., 1994. Immunogenetics, 39 (1) pp. 68-70.
 
Tissue distribution and polymorphism of minor histocompatibility antigens involved in GVHR
Miconnet I., de la Selle V., Tucek C., Huchet R., Bonardelle D., Bruley-Rosset M., 1994. Immunogenetics, 39 (3) pp. 178-86.
 
Rearrangement by chromosomal inversion in the T cell receptor gamma locus in a murine alpha beta T cell clone
Roger T., Miconnet I., Bruley-Rosset M., Seman M., 1993/12. Molecular Immunology, 30 (17) pp. 1617-20.
 
Comparison of the repertoire of T-cell lines and clones specific for minor histocompatibility antigens derived from immunized mice and from mice developing a graft-versus-host reaction
Bruley-Rosset M., Miconnet I., Roger T., Seman M., Halle-Pannenko O., 1993/02. Transplantation Proceedings, 25 (1 Pt 1) pp. 94-5.
 
Peripheral tolerance specific for host minor histocompatibility antigens in acute GVHR-protected mice is associated with functional deletion of CD4+ but not CD8+ T cells and an active suppressive mechanism
Miconnet I., Bruley-Rosset M., Halle-Pannenko O., 1993/02. Transplantation Proceedings, 25 (1 Pt 1) pp. 327-8.
 
Les clones T, moyen d'exploration des antigenes mineurs impliques dans la reaction du greffon contre l'hote. [T clones, a means of exploring minor antigens involved in graft versus host reaction]
Miconnet I., 1992/12. Presse Médicale, 21 (41) pp. 1947-50.
 
Mls-1a-induced peripheral tolerance to host minor histocompatibility antigens in radiation bone marrow chimeras. Modification of T cell repertoire associated with active suppression and permanent presentation of host antigens
Miconnet I., Bruley-Rosset M., Halle-Pannenko O., 1992/06. Journal of Immunology, 148 (12) pp. 3706-13.
 
Mlsa generated suppressor cells. I. Suppression is mediated by double-negative (CD3+CD5+CD4-CD8-) alpha/beta T cell receptor-bearing cells
Bruley-Rosset M., Miconnet I., Canon C., Halle-Pannenko O., 1990/12. Journal of Immunology, 145 (12) pp. 4046-52.
 
Graft-versus-host mortality induced by noncytolytic CD4+ T cell clones specific for non-H-2 antigens
Miconnet I., Huchet R., Bonardelle D., Motta R., Canon C., Garay-Rojas E., Kress M., Reynes M., Halle-Pannenko O., Bruley-Rosset M., 1990/10. Journal of Immunology, 145 (7) pp. 2123-31.
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Fax. +41 21 692 26 15
Swiss University